Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference5 articles.
1. Adverse cardiovascular complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched cohort study with competing risk analysis;Zhou;Cardio-Oncology,2022
2. Gastrointestinal and hepatic toxicities of checkpoint inhibitors: algorithms for management;Grover;Am Soc Clin Oncol Educ Book,2018
3. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;New Engl J Med,2015
4. Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection;Shah;J Immunother Cancer,2019
5. Grade 1 acute on chronic liver failure is a predictor for subsequent grade 3 failure;Mahmud;Hepatology,2020
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical and electrocardiographic characteristics of immune checkpoint inhibitor-related myocarditis;Journal of Electrocardiology;2024-09
2. Risk factors and outcomes of pericardial effusion in cancer patients receiving PD-1 inhibitors;International Journal of Cardiology;2024-07
3. Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis;Cancer Innovation;2024-04-15
4. Long-Term Atherosclerotic Cardiovascular Disease Risk in Patients With Cancer: A Population-Based Study;Current Problems in Cardiology;2023-07
5. PD-1/PD-L1 Blockade Accelerates the Progression of Atherosclerosis in Cancer Patients;Current Problems in Cardiology;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3